Trial Information
Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests As a Tool for Screening and Access to Care Among At-Risk Populations
Inclusion Criteria:
- At least 18 years of age
- Seeking care at the CASO MDM health care center
- Accept to be followed at Saint-Antoine Hospital in the event of a positive test.
Exclusion Criteria:
- Currently under physician's care for viral hepatitis (HBV/HCV-specific) or HIV
- Already has been tested (must give any of the following as evidence):
- results from HBV and HCV and HIV tests dating at least 3 months back
- results from HCV and HIV tests dating at least 3 months back and HBV serology
indicating that the participant is immunized against HBV.
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening
Outcome Measure:
Accessibility of testing results
Outcome Description:
The number of individuals who obtained test results for HBV, HCV, and/or HIV divided by the total number of tested individuals.
Outcome Time Frame:
Evaluated once, up to 4 months after testing
Safety Issue:
No
Principal Investigator
Julie Bottero, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Hôpital Saint-Antoine
Authority:
France: Committee for the Protection of Personnes
Study ID:
IMEA 38B
NCT ID:
NCT01790633
Start Date:
March 2013
Completion Date:
October 2013
Related Keywords:
- HIV
- Hepatitis B
- Hepatitis C
- Carcinoma, Hepatocellular
- AIDS
- rapid test
- screening
- ELISA
- hepatitis B virus
- hepatitis C virus
- human immunodeficiency virus
- access to care
- Carcinoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Carcinoma, Hepatocellular